A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
nytimes.com
31.08.2026 11:03
15 views
Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.
Related stories
Berry Recall Map Shows New Warning in 16 States for Walmart Customers
newsweek.com · 04.09
US Munitions Sent to Ukraine Compared to Iran War as Trump Blames Biden
newsweek.com · 04.09
Plans Announced to Break Ground on Trump’s Triumphal Arch Before Final Approval
nytimes.com · 04.09
Leon Black defies subpoena to testify in Epstein inquiry and sues House panel
npr.org · 04.09
Proposal for White House Visitor Screening Center Advances
nytimes.com · 04.09
Sadiq Khan agrees to have his texts and emails searched in Palantir legal battle
theguardian.com · 04.09